Clinical Trials Browser

Completed × OTHER × Solid Tumor × Clear all

NCT03447483 2026-04-14

MOTIVATE

Phase NA Completed

Other solid neoplasm

Solid Tumor

NCT06310655 2025-11-10

PARTy

Phase NA Completed

Other solid neoplasm

Solid Tumor

NCT05322408 2025-11-05

HCW9218 in Select Advanced Solid Tumors

Phase 1 Completed

18 enrolled 17 charts

Other solid neoplasm

Solid Tumor

NCT01239381 2025-09-30

Individualized Stereotactic Body Radiotherapy of Liver Metastases

Phase NA Completed

92 enrolled 13 charts

Other solid neoplasm

Solid Tumor

NCT06443710 2025-07-15

Technetium [99mTc]-H7ND in Patients With Gastrointestinal Malignancies and Healthy Volunteers

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05359718 2024-11-14

PICO SM

Other solid neoplasm

Solid Tumor

NCT04422457 2024-08-19

Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients

Phase NA Completed

Other solid neoplasm

Solid Tumor

NCT06456216 2024-06-13

Performance Evaluation of Diagnostic Accuracy of PanTum Detect Test for Detection of Solid Tumours in Known Cancer Population and in Cancer Free Population.

Other solid neoplasm

Solid Tumor

NCT04552418 2024-02-28

Intestinal Microbiome Modification With Resistant Starch in Patients Treated With Dual Immune Checkpoint Inhibitors

Phase EARLY_PHASE1 Completed

Other solid neoplasm

Solid Tumor

NCT04365413 2023-12-14

OU-SCC-MSOT

Phase NA Completed

54 enrolled 9 charts

Other solid neoplasm

Solid Tumor

NCT05412420 2023-11-30

IASAAC

Phase NA Completed

Other solid neoplasm

Solid Tumor

NCT05914142 2023-11-07

Study on the Safety and Effectiveness of Varian ProBeam Proton Therapy Equipment in the Treatment of Solid Tumors

Phase NA Completed

Other solid neoplasm

Solid Tumor

NCT03051477 2022-12-08

Trial of Mistletoe Extract in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT02447419 2022-06-15

Study to Evaluate the Safety and Efficacy of Gefitinib, in Subjects With EFGR Amplification Refractory Solid Tumors

Phase 2 Completed

Other solid neoplasm

Solid Tumor

NCT03015324 2022-01-25

Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03220854 2022-01-10

SBRT + PD-1/PDL-1 Inhibiting Therapy for Advanced Solid Tumors After Dz Control on PD-1/PDL-1 Tx

Phase 2 Completed

5 enrolled 12 charts

Other solid neoplasm

Solid Tumor

NCT03057145 2021-09-02

Combination Study of Prexasertib and Olaparib in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT00786669 2021-02-10

VITAC

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT02987166 2020-12-16

UVA-AM-001

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04079283 2020-04-02

RIREP

Other solid neoplasm

Solid Tumor

NCT02466802 2020-02-20

Study of Regorafenib and Sildenafil for Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04046016 2019-08-06

A Study Using Whole-body PET After Oral Microdose of 18F-labeled Liporaxel in Patients With Solid Tumor

Phase EARLY_PHASE1 Completed

Other solid neoplasm

Solid Tumor

NCT03130140 2018-12-06

MOSE to Improve the Diagnostic Accuracy During EUS-guided FNA Using a 19-gauge Needle for Solid Lesions

Phase NA Completed

Other solid neoplasm

Solid Tumor

NCT00215501 2018-11-02

Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT02648425 2018-10-25

Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-FU or Cisplatin and Capecitabine

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT02449564 2018-01-17

The Pilot Study Evaluate the Safety and Efficacy of Sirolimus in Patients With PIK3CA Mutation and/or PIK3CA Amplification Refractory Solid Tumors

Phase NA Completed

Other solid neoplasm

Solid Tumor

NCT02449538 2017-02-17

Study to Evaluate the Safety and Efficacy of Everolimus, in Subjects With PIK3CA Amplification, PTEN Loss and PIK3CA Mutation Refractory Solid Tumors

Phase 2 Completed

Other solid neoplasm

Solid Tumor

NCT02877589 2016-08-24

HepScreen

Other solid neoplasm

Solid Tumor

NCT00808184 2012-11-01

Pharmacokinetic Study of CPT-11, Raltegravir and Midazolam With Characterisation of UGT1A1 Genotype

Phase 4 Completed

Other solid neoplasm

Solid Tumor

NCT00483457 2012-09-03

Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients

Other solid neoplasm

Solid Tumor

NCT00251407 2012-08-09

Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies

Phase 1 Completed

Other solid neoplasm

Solid Tumor